Gabapentin is approved by the U.S. Food and Drug Administration for treatment of partial seizures and postherpetic neuralgia, but is commonly prescribed for off-label use, including neuropathic pain.
Trends in Dispensed Gabapentin Prescriptions in the United States, 2010 to 2024